Mike F. Burbridge

AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy

Jordi Bertrán-Alamillo, Valérie Cattan, Marie Schoumacher et al. · Nature Communications · 2019 · 144 citations · Full text

Improved quantification of angiogenesis in the rat aortic ring assay

Silvia Blacher, Laetitia Devy, Mike F. Burbridge et al. · Angiogenesis · 2001 · 105 citations · Full text

The role of the matrix metalloproteinases during in vitro vessel formation

Mike F. Burbridge · Angiogenesis · 2002 · 105 citations

Only a Subset of Met-Activated Pathways Are Required to Sustain Oncogene Addiction

Andrea Bertotti, Mike F. Burbridge, Stefania Gastaldi et al. · Science Signaling · 2009 · 93 citations · Full text

Tumor Onset, Cancer Biology, Tumor Biology +18

S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab

Mike F. Burbridge, Céline Bossard, Carine Saunier et al. · Molecular Cancer Therapeutics · 2013 · 86 citations

Chemoprevention Strategy, Immunology, Cancer Biology +18